PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40063049,Cell-based Immunotherapy in Esophageal Cancer.,"Mar 10, 2025",,,
40063085,"Evolution of lymphovascular space invasion in early-stage endometrial carcinoma: stratification, quantification, and clinical implications: a systematic review.","Mar 10, 2025",,,13582117716@163.com
40063095,[Perioperative chemotherapy or neoadjuvant chemoradiotherapy in the multimodal treatment of esophageal cancer-Results of the ESOPEC trial].,"Mar 10, 2025",,,lars.schiffmann@uk-koeln.de
40063100,Preclinical investigation of anti-tumor efficacy of allogeneic natural killer cells combined with cetuximab for head and neck squamous cell carcinoma.,"Mar 10, 2025","NKMAX Co., Ltd., Seongnam, Republic of Korea., NKMAX Co., Ltd., Seongnam, Republic of Korea.","NKMAX Co., Ltd., Seongnam, Republic of Korea., NKMAX Co., Ltd., Seongnam, Republic of Korea.",inspector@yuhs.ac
40063140,"Reply to the letter to the editor about ""recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis"" by Lundgren and Radros.","Mar 10, 2025",,,borje.ljungberg@umu.se
40063141,A standardized protocol for robot-assisted minimally invasive esophagectomy: improving efficiency and reducing costs.,"Mar 10, 2025",,,kitagami@phoenix-c.or.jp
40063153,A systematic review of high-grade glioma associated with Li-Fraumeni syndrome.,"Mar 10, 2025",,,Trenton.Kite@ahn.org
40063169,Correction to: Radiation-induced changes in salivary metabolite profile and pathways in head and neck cancer patients.,"Mar 10, 2025",,,
40063175,Indications and clinical outcomes in patients with soft-tissue sarcoma attached to the bone receiving tumorendoprosthetic replacement after tumor resection.,"Mar 10, 2025",,,ozturk_recep@windowslive.com
40063178,Is CO2 laser effective in the surgical management of oral potentially malignant disorders? A systematic review and meta-analysis.,"Mar 10, 2025",,,dr.vartik@gmail.com
40063190,Let-7a microRNA modulates caspase-3-dependent apoptosis in melanoma cells treated with dabrafenib and trametinib combination.,"Mar 10, 2025",,,harika.atmaca@cbu.edu.tr
40063239,Current advancement of immune function paradox of tumour-infiltrating cells and their immunotherapeutic targets: a mini-review.,"Mar 10, 2025","Department of Allied Health Sciences, Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences (NGSMIPS), NITTE (Deemed to Be University), Deralakatte, Mangaluru, 575018, Karnataka, India., Department of Allied Health Sciences, Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences (NGSMIPS), NITTE (Deemed to Be University), Deralakatte, Mangaluru, 575018, Karnataka, India., Department of Allied Health Sciences, Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences (NGSMIPS), NITTE (Deemed to Be University), Deralakatte, Mangaluru, 575018, Karnataka, India., Department of Pharmaceutical Chemistry, Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences (NGSMIPS), NITTE (Deemed to Be University), Deralakatte, Mangaluru, 575018, Karnataka, India. ronaldfernandes@nitte.edu.in.","Department of Allied Health Sciences, Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences (NGSMIPS), NITTE (Deemed to Be University), Deralakatte, Mangaluru, 575018, Karnataka, India., Department of Allied Health Sciences, Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences (NGSMIPS), NITTE (Deemed to Be University), Deralakatte, Mangaluru, 575018, Karnataka, India., Department of Allied Health Sciences, Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences (NGSMIPS), NITTE (Deemed to Be University), Deralakatte, Mangaluru, 575018, Karnataka, India., Department of Pharmaceutical Chemistry, Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences (NGSMIPS), NITTE (Deemed to Be University), Deralakatte, Mangaluru, 575018, Karnataka, India. ronaldfernandes@nitte.edu.in.",ronaldfernandes@nitte.edu.in
40063241,"PFDN1 silencing disrupts critical cancer pathways in triple-negative breast cancer: investigating migration, cell cycle, and apoptosis as a new target therapy.","Mar 10, 2025","Prince Fahad bin Sultan Chair for Biomedical Research, University of Tabuk, Tabuk, Saudi Arabia. aelmetwalli@ut.edu.sa.","Prince Fahad bin Sultan Chair for Biomedical Research, University of Tabuk, Tabuk, Saudi Arabia. aelmetwalli@ut.edu.sa.",aelmetwalli@ut.edu.sa
40063272,[Optimization of perioperative pain management: a role for a Transitional Pain Service].,"Mar 04, 2025",,,sandra.vandenheuvel@radboudumc.nl
40063281,Predictors of postoperative delirium in patients undergoing radical prostatectomy: a prospective study.,"Mar 10, 2025",,,447070480@qq.com
40063298,Impact of extended [<sup>177</sup>Lu] Lu-PSMA-617 therapy on absorbed kidney dose and CKD-EPI values: how long can therapy be safely continued?,"Mar 10, 2025",,,edanur.erdem@istanbul.edu.tr
40063304,Role of exercise on the reduction of cancer development: a mechanistic review from the lncRNA point of view.,"Mar 10, 2025",,,29879430@QQ.com
40063309,Molecular Subtypes of Breast Cancer in Arab Women: Distribution and Prognostic Insights.,"Mar 10, 2025","Cancer Biology and Experimental Therapeutics Section, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, KSA, Saudi Arabia.","Cancer Biology and Experimental Therapeutics Section, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, KSA, Saudi Arabia.",nelkum@kfshrc.edu.sa
40063312,Principal component analysis and fine-tuned vision transformation integrating model explainability for breast cancer prediction.,"Mar 10, 2025",,,nthai.cit@ctu.edu.vn
40063314,Integrative Phosphoproteomic and Metabolomic Analysis of Disruption of Metabolic Homeostasis in Breast Cancer: A Pilot Study.,"Mar 10, 2025","College of Life Science, Northwest Normal University, Lanzhou, 730070, Gansu Province, China. xzhuaf@nwnu.edu.cn.","College of Life Science, Northwest Normal University, Lanzhou, 730070, Gansu Province, China. xzhuaf@nwnu.edu.cn.",xzhuaf@nwnu.edu.cn
40063317,PTEN inactivating mutations are associated with hormone receptor loss during breast cancer recurrence.,"Mar 10, 2025",,,haiying.zhan@yale.edu
40063331,Retrospective nationwide survey of pediatric RDD in Japan: a high prevalence of mutations in the kinase pathway genes.,"Mar 10, 2025",,,akira@jichi.ac.jp
40063332,Frequency and predictors of caregiver burden among patients with cancer receiving palliative cancer treatment.,"Mar 10, 2025",,,torrestenor@yahoo.es
40063337,Monotherapy vs combination therapy evaluation of FDA-approved TKIs targeting PDGFR for the treatment of thyroid cancer.,"Mar 10, 2025","Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education &amp; Research, Jamia Hamdard, New Delhi, India., Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraydah, Saudi Arabia., Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education &amp; Research, Jamia Hamdard, New Delhi, India., Department of Pharmaceutical Chemistry, DIPSAR, Delhi Pharmaceutical Science and Research University (DPSRU), New Delhi, India., Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education &amp; Research, Jamia Hamdard, New Delhi, India., Department of Pharmacology, School of Pharmaceutical Education &amp; Research, Jamia Hamdard, New Delhi, India., Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education &amp; Research, Jamia Hamdard, New Delhi, India., Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education &amp; Research, Jamia Hamdard, New Delhi, India., Department of Pharmacology, School of Pharmaceutical Education &amp; Research, Jamia Hamdard, New Delhi, India., Department of Artificial Intelligence and Precision Medicine, Delhi Pharmaceutical Sciences and Research University, New Delhi, India., Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education &amp; Research, Jamia Hamdard, New Delhi, India.","Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education &amp; Research, Jamia Hamdard, New Delhi, India., Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraydah, Saudi Arabia., Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education &amp; Research, Jamia Hamdard, New Delhi, India., Department of Pharmaceutical Chemistry, DIPSAR, Delhi Pharmaceutical Science and Research University (DPSRU), New Delhi, India., Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education &amp; Research, Jamia Hamdard, New Delhi, India., Department of Pharmacology, School of Pharmaceutical Education &amp; Research, Jamia Hamdard, New Delhi, India., Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education &amp; Research, Jamia Hamdard, New Delhi, India., Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education &amp; Research, Jamia Hamdard, New Delhi, India., Department of Pharmacology, School of Pharmaceutical Education &amp; Research, Jamia Hamdard, New Delhi, India., Department of Artificial Intelligence and Precision Medicine, Delhi Pharmaceutical Sciences and Research University, New Delhi, India., Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education &amp; Research, Jamia Hamdard, New Delhi, India.",
40063340,Prevention of herpes zoster in acquired immunocompromised conditions: Review of updates and perspectives from Hong Kong.,"Dec 10, 2025","Department of Medicine and Therapeutics, Division of Nephrology, The Chinese University of Hong Kong, Hong Kong., Department of Medicine and Therapeutics, Division of Rheumatology, The Chinese University of Hong Kong, Hong Kong., Sir YK Pao Centre for Cancer &amp; Department of Medicine and Therapeutics, Division of Haematology, The Chinese University of Hong Kong, Hong Kong., State Key Laboratory of Translational Oncology, Department of Clinical Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.","Department of Medicine and Therapeutics, Division of Nephrology, The Chinese University of Hong Kong, Hong Kong., Department of Medicine and Therapeutics, Division of Rheumatology, The Chinese University of Hong Kong, Hong Kong., Sir YK Pao Centre for Cancer &amp; Department of Medicine and Therapeutics, Division of Haematology, The Chinese University of Hong Kong, Hong Kong., State Key Laboratory of Translational Oncology, Department of Clinical Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.",
40063343,Modular Synthesis of Bioactive Selenoheterocycles for Efficient Cancer Therapy via Electrochemical Selenylation/Cyclization.,"Mar 10, 2025","Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China.","Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China., Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target &amp; Clinical Pharmacology, The State &amp; NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China.",
40063360,Mechanistic Insights into SENP1 and OCT4 Interaction in Promoting Drug Resistance and Stem Cell Features in Colon Cancer.,"Mar 10, 2025","Department of Abdominal Oncology Surgery, Jiangxi Cancer Hospital, Nanchang, 330000, Jiangxi Province, China., Department of nursing, Nanchang Medical College, Nanchang, 330000, Jiangxi Province, China., Department of Medical Oncology, Jiangxi Cancer Hospital, Nanchang, 330000, Jiangxi Province, China., Department of Abdominal Oncology Surgery, Jiangxi Cancer Hospital, Nanchang, 330000, Jiangxi Province, China., Department of Breast Surgery, Jiangxi Cancer Hospital, Nanchang, 330000, Jiangxi Province, China., General Surgery Department of the Trauma Center of Nanchang First Hospital, Nanchang, 330000, Jiangxi Province, China., Department of Breast Surgery, Jiangxi Cancer Hospital, Nanchang, 330000, Jiangxi Province, China.","Department of Abdominal Oncology Surgery, Jiangxi Cancer Hospital, Nanchang, 330000, Jiangxi Province, China., Department of nursing, Nanchang Medical College, Nanchang, 330000, Jiangxi Province, China., Department of Medical Oncology, Jiangxi Cancer Hospital, Nanchang, 330000, Jiangxi Province, China., Department of Abdominal Oncology Surgery, Jiangxi Cancer Hospital, Nanchang, 330000, Jiangxi Province, China., Department of Breast Surgery, Jiangxi Cancer Hospital, Nanchang, 330000, Jiangxi Province, China., General Surgery Department of the Trauma Center of Nanchang First Hospital, Nanchang, 330000, Jiangxi Province, China., Department of Breast Surgery, Jiangxi Cancer Hospital, Nanchang, 330000, Jiangxi Province, China.",
40063363,Recent advances in nano-molybdenum oxide for photothermal cancer therapy.,"Mar 10, 2025","Key Laboratory for Information Photonic Technology of ShaanXi Province &amp; Key Laboratory for Physical Electronics and Devices of the Ministry of Education, School of Electronic Science and Engineering, Faculty of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, China.","Key Laboratory for Information Photonic Technology of ShaanXi Province &amp; Key Laboratory for Physical Electronics and Devices of the Ministry of Education, School of Electronic Science and Engineering, Faculty of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, China.",
40063380,The Role of Palliative Nursing in the Context of Immunotherapies: A Scoping Review of Patient- and Family-Centered Care Considerations.,"Mar 10, 2025",,,
40063504,The spectrum of IDH- and H3-wildtype high-grade glioma subgroups occurring across teenage and young adult patient populations.,"Mar 10, 2025",,,
40063511,A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy.,"Feb 21, 2025","ProMab Biotechnologies., ProMab Biotechnologies., ProMab Biotechnologies., ProMab Biotechnologies., ProMab Biotechnologies., ProMab Biotechnologies., ProMab Biotechnologies., ProMab Biotechnologies., ProMab Biotechnologies., ProMab Biotechnologies; vita.gol@promab.com., ProMab Biotechnologies; john@promab.com.","ProMab Biotechnologies., ProMab Biotechnologies., ProMab Biotechnologies., ProMab Biotechnologies., ProMab Biotechnologies., ProMab Biotechnologies., ProMab Biotechnologies., ProMab Biotechnologies., ProMab Biotechnologies., ProMab Biotechnologies; vita.gol@promab.com., ProMab Biotechnologies; john@promab.com.",vita.gol@promab.com
40063535,Efficacy of disitamab vedotin (RC48) for previously treated human epidermal growth factor receptor 2-positive breast cancer with symptomatic brain metastases: a case report and review of the literature.,"Mar 04, 2025","Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, China., Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, China., Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, China., Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, China., Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, China.","Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, China., Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, China., Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, China., Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, China., Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, China.",
40063539,"Implementation of chimeric antigen receptor (CAR) T-cell therapy in the NHS: prospects, promises and pitfalls.","Mar 06, 2025",,,
40063540,Cancer nursing research priorities: findings from a cancer nurses' consultation in Europe.,"Mar 06, 2025",,,
40063552,A qualitative study exploring the experiences of nurses delivering bacillus Calmette-Gu&#xe9;rin therapy.,"Mar 06, 2025",,,
40063560,Introduction of AGPAT3 gene as a regulator of cisplatin resistance in A2780 ovarian endometrioid carcinoma cell line.,"03 10, 2025",,,
40063583,Multimodal prehabilitation in people awaiting acute inpatient cardiac surgery: Study protocol for a pilot feasibility trial (PreP-ACe).,"03 10, 2025",,,
40063607,Response to pembrolizumab in advanced prostate cancer with predictive biomarkers.,"Mar 10, 2025",,,
40063609,Classification of NK-large granular lymphocytic leukemia by CD56 expression.,"Mar 10, 2025",,,
40063610,Managing elderly patients with dual metastatic cancers-navigating diagnostic and treatment challenges.,"Mar 10, 2025",,,
40063611,Prognostic relevance of immunoglobulin heavy chain rearrangement and immunoglobulin kappa light chain rearrangement in patients with diffuse large B cell lymphoma.,"Mar 10, 2025","Shanghai Rightongene Biotechnology Co., Ltd., Shanghai 201403, China., Shanghai Rightongene Biotechnology Co., Ltd., Shanghai 201403, China., Shanghai Rightongene Biotechnology Co., Ltd., Shanghai 201403, China., Shanghai Rightongene Biotechnology Co., Ltd., Shanghai 201403, China.","Shanghai Rightongene Biotechnology Co., Ltd., Shanghai 201403, China., Shanghai Rightongene Biotechnology Co., Ltd., Shanghai 201403, China., Shanghai Rightongene Biotechnology Co., Ltd., Shanghai 201403, China., Shanghai Rightongene Biotechnology Co., Ltd., Shanghai 201403, China.",
40063612,Efficacy of atezolizumab combined with platinum and etoposide in the treatment of extrapulmonary neuroendocrine carcinoma.,"Mar 10, 2025","Chang Institute of Biopharmaceutical Science, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.","Chang Institute of Biopharmaceutical Science, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.",
40063639,Exploring the experiences of cancer patients: What drives them to seek treatment outside their residential area and what are the experiences resulting from that decision? A qualitative study.,"03 10, 2025",,,
40063657,Effectiveness of rehabilitation training on radiotherapy-related abnormalities of voice function in head and neck cancer patients: A systematic review and meta-analysis.,"03 10, 2025","Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China., Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China., Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China., Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China.","Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China., Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China., Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China., Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China.",
40063659,"Factors associated with uptake of human papilloma virus vaccine among adolescent girls: A cross sectional survey on insights into HPV Infection Prevention in Kabarole District, Western Uganda.","03 10, 2025",,,
40063683,Evaluating the Impact of Induction and Consolidation Total Neoadjuvant Therapies Compared to Conventional Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Network Meta-analysis.,"Mar 11, 2025",,,
40063738,Molecular insights into the antineoplastic potential of apigenin and its derivatives: paving the way for nanotherapeutic innovations.,"Mar 10, 2025","Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India., Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India., Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India.","Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India., Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India., Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India.",
40063748,A content review of COVID-19-related apps used in Vietnam.,"Feb 28, 2025","Faculty of Medicine, College of Medicine and Pharmacy, Duy Tan University, Da Nang City, 550000, Vietnam.","Faculty of Medicine, College of Medicine and Pharmacy, Duy Tan University, Da Nang City, 550000, Vietnam.",
40063817,"Usability, Acceptability, and Barriers to Implementation of a Collaborative Agenda-Setting Intervention (CASI) to Promote Person-Centered Ovarian Cancer Care: Development Study.","Mar 10, 2025",,,
40063826,Clinical Outcomes of Chemo-Immunotherapy for Extensive Stage Small Cell Lung Cancer: A Real-World Single Centre Study in Portugal.,"Mar 10, 2025",,,
40063839,Navigating the Complexity: Management of Acute Myocardial Infarction With Intracranial Hemorrhage.,"Mar 10, 2025","Division Chief Geriatrics, Vice Chair Diversity Equity and Inclusion RWJMS, Monroe, NJ.","Division Chief Geriatrics, Vice Chair Diversity Equity and Inclusion RWJMS, Monroe, NJ.",
40063841,Pyrazolopyrimidines: A promising frontier in cancer treatment- Reviewing their potential as inhibitors of serine/threonine kinases.,"Mar 10, 2025","Misr University for Science and Technology, Pharmaceutical Organic Chemistry Department,, October, 6 october, EGYPT., Misr University for Science and Technology, Pharmaceutical Organic Chemistry Department,, October, October, EGYPT., Cairo University Faculty of Pharmacy, Pharmaceutical Organic Chemistry Department, Kasr Elini, Cairo, EGYPT., Cairo University Faculty of Pharmacy, Pharmaceutical Orghanic Chemistry, Kasr Elinin street, 00000, Cairo, EGYPT.","Misr University for Science and Technology, Pharmaceutical Organic Chemistry Department,, October, 6 october, EGYPT., Misr University for Science and Technology, Pharmaceutical Organic Chemistry Department,, October, October, EGYPT., Cairo University Faculty of Pharmacy, Pharmaceutical Organic Chemistry Department, Kasr Elini, Cairo, EGYPT., Cairo University Faculty of Pharmacy, Pharmaceutical Orghanic Chemistry, Kasr Elinin street, 00000, Cairo, EGYPT.",
40063872,Anatomy education potential of the first digital twin of a Korean cadaver.,"03 10, 2025",,,
40063881,Second-intention Healing Combined with ALA-PDT in the Treatment of Periocular Basal Cell Carcinoma.,"Mar 10, 2025",,,reprints@oup.com
40063899,Pistol Ribozyme-Driven Catalytic Spherical Nucleic Acid Integrates Gene and Chemotherapy for Enhanced Cancer Therapy.,"Mar 10, 2025","State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for New Organic Matter, Frontiers Science Center for Cell Responses and College of Pharmacy, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin 300071, China., State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin 300071, China., State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin 300071, China., State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin 300071, China., State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin 300071, China., State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin 300071, China., State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin 300071, China., China Regional Research Centre, International Centre of Genetic Engineering and Biotechnology, Taizhou 212200, China., State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for New Organic Matter, Frontiers Science Center for Cell Responses and College of Pharmacy, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin 300071, China.","State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for New Organic Matter, Frontiers Science Center for Cell Responses and College of Pharmacy, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin 300071, China., State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin 300071, China., State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin 300071, China., State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin 300071, China., State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin 300071, China., State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin 300071, China., State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin 300071, China., China Regional Research Centre, International Centre of Genetic Engineering and Biotechnology, Taizhou 212200, China., State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for New Organic Matter, Frontiers Science Center for Cell Responses and College of Pharmacy, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin 300071, China.",
40063923,Spectacular effect of radiotherapy in a 91-year-old man with locally advanced lip cancer: a case report and reflections on palliative care.,"3 10, 2025",,,
40063925,Hybrid Anticancer Peptide Synergistically Improving Cancer Cell Uptake and Inducing Apoptosis Mediated by Membrane Fusion.,"Mar 10, 2025",,,
40063931,Prehabilitation Program for Lung and Esophageal Cancers (Boosting Recovery and Activity Through Early Wellness): Protocol for a Nonrandomized Trial.,"Mar 10, 2025",,,
40063947,Development of a Voice-Activated Virtual Assistant to Improve Insomnia Among Young Adult Cancer Survivors: Mixed Methods Feasibility and Acceptability Study.,"Mar 10, 2025",,,
40063980,Cost-utility analysis of pembrolizumab versus nivolumab in the treatment of metastatic colorectal cancer from the perspective of the healthcare payer.,"Mar 10, 2025",,,
40063999,Intramedullary primary spinal cord melanoma: illustrative case.,"Mar 10, 2025",,,
40064003,Tumor-to-tumor metastasis of clear cell renal cell carcinoma to meningioma: illustrative case.,"Mar 10, 2025",,,
40064013,Not one size fits all: a half-mask-based GKRS treatment for preservation of a scalp flap. Illustrative case.,"Mar 10, 2025",,,
40064065,"""Complex segmentectomies: Comparison with simple and effect of experience on postoperative outcomes"".","Mar 05, 2025",,,carlos.galvez.cto@gmail.com
40064067,HSP110 T17 marker matches the pentaplex panel and outperforms CAT-25 for detecting microsatellite instability in sporadic colorectal cancer.,"Mar 06, 2025",,,rajoua.med.nasreddine@gmail.com
40064135,Resilient STR loci under gamma radiation: A preliminary study on DNA stability in buccal swabs.,"Mar 06, 2025","Faculty of Biotechnology, MSA University, 6th of October City, Egypt.","Faculty of Biotechnology, MSA University, 6th of October City, Egypt.",amani.f.kraishan@ahu.edu.jo
40064143,Mitochondrial DNA-targeted triphenylamine-thiophene (TPATP)-derived ligands boost type-I/II photodynamic therapy for triple-negative breast cancer.,"Mar 07, 2025","Nation-Regional Engineering Lab for Synthetic Biology of Medicine, International Cancer Center, School of Pharmacy, Shenzhen University Medical School, Shenzhen, 518060, China., Nation-Regional Engineering Lab for Synthetic Biology of Medicine, International Cancer Center, School of Pharmacy, Shenzhen University Medical School, Shenzhen, 518060, China., Nation-Regional Engineering Lab for Synthetic Biology of Medicine, International Cancer Center, School of Pharmacy, Shenzhen University Medical School, Shenzhen, 518060, China., Nation-Regional Engineering Lab for Synthetic Biology of Medicine, International Cancer Center, School of Pharmacy, Shenzhen University Medical School, Shenzhen, 518060, China. Electronic address: humhao1229@szu.edu.cn.","Nation-Regional Engineering Lab for Synthetic Biology of Medicine, International Cancer Center, School of Pharmacy, Shenzhen University Medical School, Shenzhen, 518060, China., Nation-Regional Engineering Lab for Synthetic Biology of Medicine, International Cancer Center, School of Pharmacy, Shenzhen University Medical School, Shenzhen, 518060, China., Nation-Regional Engineering Lab for Synthetic Biology of Medicine, International Cancer Center, School of Pharmacy, Shenzhen University Medical School, Shenzhen, 518060, China., Nation-Regional Engineering Lab for Synthetic Biology of Medicine, International Cancer Center, School of Pharmacy, Shenzhen University Medical School, Shenzhen, 518060, China. Electronic address: humhao1229@szu.edu.cn.",humhao1229@szu.edu.cn
40064154,Development of obesity following treatment for childhood malignancies.,"Mar 10, 2025",,,
40064175,Mitochondria-based medicine.,"3 11, 2025",,,
40064181,Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors.,"Mar 10, 2025",,,
40064200,Breast Cancer Biopsies With Group 2 and Group 4 Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization Results Should Have Repeated Testing on Excision.,"Mar 11, 2025",,,
40064225,Unraveling rosmarinic acid anticancer mechanisms in oral cancer malignant transformation.,"Mar 08, 2025","Univ Coimbra, Faculty of Pharmacy, Coimbra, Portugal; REQUIMTE/LAQV, Drug Development and Technologies Laboratory, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal; Institute for Clinical and Biomedical Research (iCBR) area of Environment Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, Coimbra, Portugal., Univ Coimbra, Faculty of Pharmacy, Coimbra, Portugal; Instituto de Investiga&#xe7;&#xe3;o e Inova&#xe7;&#xe3;o em Sa&#xfa;de, University of Porto, Porto, Portugal., Univ Coimbra, Faculty of Pharmacy, Coimbra, Portugal; Chemical Engineering and Renewable Resources for Sustainability, CERES, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal., Univ Coimbra, Faculty of Pharmacy, Coimbra, Portugal; REQUIMTE/LAQV, Drug Development and Technologies Laboratory, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal., Univ Coimbra, Faculty of Pharmacy, Coimbra, Portugal; Coimbra Chemistry Centre, Institute of Molecular Sciences-IMS, Faculty of Sciences and Technology, University of Coimbra, Coimbra, Portugal., Univ Coimbra, Faculty of Pharmacy, Coimbra, Portugal; REQUIMTE/LAQV, Drug Development and Technologies Laboratory, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal. Electronic address: rfigueiras@ff.uc.pt.","Univ Coimbra, Faculty of Pharmacy, Coimbra, Portugal; REQUIMTE/LAQV, Drug Development and Technologies Laboratory, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal; Institute for Clinical and Biomedical Research (iCBR) area of Environment Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, Coimbra, Portugal., Univ Coimbra, Faculty of Pharmacy, Coimbra, Portugal; Instituto de Investiga&#xe7;&#xe3;o e Inova&#xe7;&#xe3;o em Sa&#xfa;de, University of Porto, Porto, Portugal., Univ Coimbra, Faculty of Pharmacy, Coimbra, Portugal; Chemical Engineering and Renewable Resources for Sustainability, CERES, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal., Univ Coimbra, Faculty of Pharmacy, Coimbra, Portugal; REQUIMTE/LAQV, Drug Development and Technologies Laboratory, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal., Univ Coimbra, Faculty of Pharmacy, Coimbra, Portugal; Coimbra Chemistry Centre, Institute of Molecular Sciences-IMS, Faculty of Sciences and Technology, University of Coimbra, Coimbra, Portugal., Univ Coimbra, Faculty of Pharmacy, Coimbra, Portugal; REQUIMTE/LAQV, Drug Development and Technologies Laboratory, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal. Electronic address: rfigueiras@ff.uc.pt.",rfigueiras@ff.uc.pt
40064226,&#x3b2;-elemene: A promising natural compound in lung cancer therapy.,"Mar 08, 2025","Department of Pediatrics, Shengjing Hospital, China Medical University, Shenyang, Liaoning Province, 110004, China., Department of Critical Care Medicine, The First Affiliated Hospital, China Medical University, Shenyang, Liaoning Province, 110001, China., Department of Pediatrics, Shengjing Hospital, China Medical University, Shenyang, Liaoning Province, 110004, China. Electronic address: danzhangedu@gmail.com.","Department of Pediatrics, Shengjing Hospital, China Medical University, Shenyang, Liaoning Province, 110004, China., Department of Critical Care Medicine, The First Affiliated Hospital, China Medical University, Shenyang, Liaoning Province, 110001, China., Department of Pediatrics, Shengjing Hospital, China Medical University, Shenyang, Liaoning Province, 110004, China. Electronic address: danzhangedu@gmail.com.",danzhangedu@gmail.com
40064250,Consolidative Radiotherapy in Oligometastatic and Oligoprogressive NSCLC: A Systematic Review.,"Mar 08, 2025",,,nagasakm@hs.uci.edu
40064251,"Artificial Intelligence and Whole Slide Imaging, a new tool for the Microsatellite Instability prediction in Colorectal Cancer: friend or foe?","Mar 08, 2025",,,a.cannarozzi@operapadrepio.it
40064252,FK506-binding proteins: Emerging target and therapeutic opportunity in multiple tumors.,"Mar 08, 2025","Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China., Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China., Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China., Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China., Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China., Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China., Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China., Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China., Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China., Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China. Electronic address: chenweijun@hmc.edu.cn., Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China. Electronic address: 11718266@zju.edu.cn.","Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China., Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China., Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China., Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China., Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China., Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China., Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China., Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China., Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China., Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China. Electronic address: chenweijun@hmc.edu.cn., Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China. Electronic address: 11718266@zju.edu.cn.",chenweijun@hmc.edu.cn
40064253,Blocking ATF4 attenuates pulmonary fibrosis by preventing lung fibroblast activation and macrophage M2 program.,"Mar 08, 2025",,,zhenshun_cheng@126.com
40064263,Designing pegylated dextran sheathed doxorubicin loaded iron nanoparticles against premenopausal breast cancer.,"Mar 08, 2025","Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh 201002, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh 201002, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh 201002, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh 201002, India. Electronic address: manish_chourasia@cdri.res.in.","Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh 201002, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh 201002, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh 201002, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India., Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh 201002, India. Electronic address: manish_chourasia@cdri.res.in.",manish_chourasia@cdri.res.in
40064279,NEK2 inhibition reverses vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.,"Mar 08, 2025","Department of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo City, Zhejiang Province 315010, China. Electronic address: fyyluochunlei@nbu.edu.cn.","Department of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo City, Zhejiang Province 315010, China. Electronic address: fyyluochunlei@nbu.edu.cn.",fyyluochunlei@nbu.edu.cn
40064292,Title: Adding Adjuvant Drugs From Distinct Breast Cancer Trials.,"Mar 08, 2025",,,timothee.olivier@hug.ch
40064294,Quality of life and emotional state of patients who are candidates for CAR-T therapy: Role of the advanced practice nurse.,"Mar 08, 2025",,,mmontoro@clinic.cat
40064297,"Real-world evidence regarding cancer, mortality, and graft failure risk with de novo belatacept use among kidney transplant recipients in the United States.","Mar 08, 2025",,,shyfuddin.ahmed@nih.gov
40064312,Facility exposure to wildfire disasters and hospital length of stay following lung cancer surgery.,"Mar 11, 2025",,,reprints@oup.com
40064358,Integrated analysis of single-cell and bulk RNA sequencing identifies APOC1 as a biomarker and therapeutic target for G0/G1 cell cycle arrest in cholangiocarcinoma.,"Mar 08, 2025","Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China., Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China. Electronic address: sunzhaowei0920@163.com., Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China., Medical Department of Qingdao University, Qingdao City, Shandong Province 266000, China., Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China., Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China., Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China., Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China., Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China., Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China., Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China., Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China. Electronic address: fengyj1943@163.com.","Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China., Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China. Electronic address: sunzhaowei0920@163.com., Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China., Medical Department of Qingdao University, Qingdao City, Shandong Province 266000, China., Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China., Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China., Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China., Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China., Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China., Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China., Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China., Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, China. Electronic address: fengyj1943@163.com.",sunzhaowei0920@163.com
40064365,miR-124-mediated temozolomide sensitivity and DNA repair modulation in Glioblastoma Multiforme.,"Mar 08, 2025","Department of Biotechnology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran.","Department of Biotechnology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran.",arefian@ut.ac.ir
40064384,Deciphering a crosstalk between biological cues and multifunctional nanocarriers in lung cancer therapy.,"Mar 08, 2025","Y. B. Chavan College of Pharmacy, Dr. Rafiq Zakaria Campus, Rauza Baugh, Aurangabad 431001, India.","Y. B. Chavan College of Pharmacy, Dr. Rafiq Zakaria Campus, Rauza Baugh, Aurangabad 431001, India.",manash.paul@manipal.edu
40064385,Formulation and evaluation of an oxygen microbubble stabilised in a hydrogel to potentiate radiotherapy.,"Mar 08, 2025","School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand., School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand., School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand., School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand., School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. Electronic address: s.thakur@auckland.ac.nz.","School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand., School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand., School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand., School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand., School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. Electronic address: s.thakur@auckland.ac.nz.",s.thakur@auckland.ac.nz
40064440,SRSF9 mediates oncogenic RNA splicing of SLC37A4 via liquid-liquid phase separation to promote oral cancer progression.,"Mar 08, 2025","Department of Oncology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha 410005 Hunan, China. Electronic address: march-on@126.com.","Department of Oncology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha 410005 Hunan, China. Electronic address: march-on@126.com.",march-on@126.com
40064476,Highlights of 2024. Broadening anti-cancer immunotherapy modalities with antibody-drug conjugates: emerging insights from clinical studies.,"Mar 10, 2025",,,
40064481,Neoadjuvant treatment for incidental gallbladder cancer: A systematic review.,"Mar 11, 2025",,,
40064489,[Sex-Based Differences and Shared Decision-Making in Myasthenia Gravis].,2025 Mar,,,
40064495,Survey on the Use of Surgical Navigation for Endoscopic Sinus Surgery in the UK.,2025 Mar 10,,,
40064521,Impact of Dietary Behavioural Changes on Prognosis of Postoperative Oesophageal Squamous Cell Carcinoma Patients: A Retrospective Cohort Study.,2025 Mar,,,
40064543,Bone marrow mesenchymal stem cells improve bone cancer pain by inhibiting p38MAPK phosphorylation and microglia activation.,"Mar 11, 2025","Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, China., Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou Medical University, Xuzhou, China., Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, China., Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou Medical University, Xuzhou, China., Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, China., Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou Medical University, Xuzhou, China., Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, China., Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou Medical University, Xuzhou, China., Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, China., Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou Medical University, Xuzhou, China.","Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, China., Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou Medical University, Xuzhou, China., Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, China., Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou Medical University, Xuzhou, China., Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, China., Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou Medical University, Xuzhou, China., Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, China., Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou Medical University, Xuzhou, China., Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, China., Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou Medical University, Xuzhou, China.",
40064548,"Correction to ""Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione Derivative Inhibits d-Dopachrome Tautomerase Activity and Suppresses the Proliferation of Non-Small Cell Lung Cancer Cells"".",2025 Mar 10,,,
40064560,"Chinese Association of Ultrasound in Medicine and Engineering, Superficial Organs and Peripheral Vessels Committee Expert Consensus on Selected Common Clinical Issues in Parathyroid Ultrasound (2024 Edition).","Mar 09, 2025","Department of Ultrasound, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China., Department of Ultrasound, Guangdong Provincial People's Hospital, Guangzhou, China., Department of Ultrasound, Anhui Provincial Hospital, Hefei, China., Department of Ultrasound, Shanxi Provincial People's Hospital, Taiyuan, China.","Department of Ultrasound, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China., Department of Ultrasound, Guangdong Provincial People's Hospital, Guangzhou, China., Department of Ultrasound, Anhui Provincial Hospital, Hefei, China., Department of Ultrasound, Shanxi Provincial People's Hospital, Taiyuan, China.",luobm@mail.sysu.edu.cn
40064569,"Prevalence of homologous recombination deficiency among women with newly diagnosed ovarian, primary peritoneal, and/or fallopian tube cancer: the international HALO study.",2025 Jan 17,,,
40064572,Brief Report: Real-World Clinical Utility of Next-Generation Sequencing of Circulating Tumor DNA for Patients With Advanced Lung Squamous Cell Carcinoma (SQUIN).,2025 Feb 14,,,
40064573,"The PESGA Trial: A Prospective, Open-Label, Single-Arm, Phase II Study to Evaluate First Line Therapy for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Patients, Treated by Induction Carboplatin/Etoposide/Pembrolizumab Followed by Maintenance of Pembrolizumab/ Sacituzumab Govitecan.",2025 Feb 13,,,
40064574,Racial Diversity and Co-Mutational Analysis of Biologically Relevant Alterations in EGFR Mutant Lung Cancers.,"Feb 14, 2025","Tempus AI, Inc, Chicago, IL., Tempus AI, Inc, Chicago, IL., Tempus AI, Inc, Chicago, IL., Tempus AI, Inc, Chicago, IL.","Tempus AI, Inc, Chicago, IL., Tempus AI, Inc, Chicago, IL., Tempus AI, Inc, Chicago, IL., Tempus AI, Inc, Chicago, IL.",rgutta1@hfhs.org
40064578,Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation Therapy.,2025 Mar 9,,,
40064590,Mental Health Challenges in Cancer Survivors From Diverse Backgrounds During COVID-19 Pandemic: Insights From the All of Us Research Program.,2025 Mar,,,
40064599,Diagnostic Performance of GPT-4o and Gemini Flash 2.0 in Acne and Rosacea.,2025 Mar 10,,,
40064603,Causes of Monodactylous Onycholysis in a Diverse Patient Population.,2025 Mar 10,,,
40064605,The Lives of Older People With Advanced Cancer Who Live Alone During Outpatient Cancer Chemotherapy: A Descriptive Qualitative Study.,2025 Mar,,,
40064606,Skin Cancers in People With Albinism: An Overview and Review of Literature.,2025 Mar 10,,,
40064612,Examining Farnesyltransferase Interaction With Cell-Permeable CaaX Peptides and the Role of the CaaX Motif in Biological Activity.,2025 Apr,,,
40064621,Adding New Components to a Composite Quality Metric: How Good Is Good Enough?,2025 Apr 1,,,
40064631,Intraventricular mass in a 52-year-old woman.,2025 Mar 10,,,

